关注
Sjoukje Oosting
Sjoukje Oosting
Medical Oncologist, University Medical Center Groningen
在 umcg.nl 的电子邮件经过验证
标题
引用次数
引用次数
年份
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised …
B Burtness, KJ Harrington, R Greil, D Soulières, M Tahara, G de Castro, ...
The Lancet 394 (10212), 1915-1928, 2019
23652019
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised …
RJ Motzer, BI Rini, DF McDermott, OA Frontera, HJ Hammers, ...
The Lancet Oncology 20 (10), 1370-1385, 2019
7232019
89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer
F Bensch, EL van der Veen, MN Lub-de Hooge, A Jorritsma-Smit, ...
Nature medicine 24 (12), 1852-1858, 2018
5932018
Prognostic versus predictive value of biomarkers in oncology
C Oldenhuis, SF Oosting, JA Gietema, EGE De Vries
European journal of cancer 44 (7), 946-953, 2008
4642008
The metabolic syndrome in cancer survivors
EC De Haas, SF Oosting, JD Lefrandt, BHR Wolffenbuttel, DT Sleijfer, ...
The lancet oncology 11 (2), 193-203, 2010
2632010
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial
SF Oosting, AAM van der Veldt, CH GeurtsvanKessel, RSN Fehrmann, ...
The Lancet Oncology 22 (12), 1681-1691, 2021
1542021
89Zr-bevacizumab PET visualizes heterogeneous tracer accumulation in tumor lesions of renal cell carcinoma patients and differential effects of antiangiogenic treatment
SF Oosting, AH Brouwers, SC van Es, WB Nagengast, THO Munnink, ...
Journal of Nuclear Medicine 56 (1), 63-69, 2015
1412015
VEGF-PET imaging is a noninvasive biomarker showing differential changes in the tumor during sunitinib treatment
WB Nagengast, MN Lub-de Hooge, SF Oosting, WFA den Dunnen, ...
Cancer research 71 (1), 143-153, 2011
1412011
Bevacizumab-induced normalization of blood vessels in tumors hampers antibody uptake
M Arjaans, TH Oude Munnink, SF Oosting, ...
Cancer research 73 (11), 3347-3355, 2013
1382013
Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations
AL Ho, I Brana, R Haddad, J Bauman, K Bible, S Oosting, DJ Wong, ...
Journal of Clinical Oncology 39 (17), 1856-1864, 2021
1352021
VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside
M Arjaans, CP Schröder, SF Oosting, U Dafni, JE Kleibeuker, ...
Oncotarget 7 (16), 21247, 2016
1252016
Development of a multivariable normal tissue complication probability (NTCP) model for tube feeding dependence after curative radiotherapy/chemo-radiotherapy in head and neck …
K Wopken, HP Bijl, A van der Schaaf, HP van der Laan, O Chouvalova, ...
Radiotherapy and Oncology 113 (1), 95-101, 2014
1212014
Androgen deprivation therapy for androgen receptor‐positive advanced salivary duct carcinoma: a nationwide case series of 35 patients in The Netherlands
E Boon, W van Boxtel, J Buter, RJ Baatenburg de Jong, RJJ van Es, M Bel, ...
Head & neck 40 (3), 605-613, 2018
1192018
A prospective cohort study on radiation-induced hypothyroidism: development of an NTCP model
MJ Boomsma, HP Bijl, MEMC Christianen, I Beetz, O Chouvalova, ...
International Journal of Radiation Oncology* Biology* Physics 84 (3), e351-e356, 2012
1162012
Acute symptoms during the course of head and neck radiotherapy or chemoradiation are strong predictors of late dysphagia
HP van der Laan, HP Bijl, RJHM Steenbakkers, A van der Schaaf, ...
Radiotherapy and Oncology 115 (1), 56-62, 2015
1092015
A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from T he N etherlands
E Boon, M Bel, W van Boxtel, WTA van der Graaf, RJJ van Es, ...
International journal of cancer 143 (4), 758-766, 2018
1042018
Patterns of long-term swallowing dysfunction after definitive radiotherapy or chemoradiation
MEMC Christianen, IM Verdonck-de Leeuw, P Doornaert, O Chouvalova, ...
Radiotherapy and Oncology 117 (1), 139-144, 2015
1012015
Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy
MI van Rijn-Dekker, L van den Bosch, JGM van den Hoek, HP Bijl, ...
Radiotherapy and Oncology 147, 103-110, 2020
992020
Polymorphisms in Endothelial Nitric Oxide Synthase (eNOS) and Vascular Endothelial Growth Factor (VEGF) Predict Sunitinib‐Induced Hypertension
K Eechoute, AAM Van Der Veldt, S Oosting, MHW Kappers, JAM Wessels, ...
Clinical Pharmacology & Therapeutics 92 (4), 503-510, 2012
992012
Dopamine and serotonin regulate tumor behavior by affecting angiogenesis
MAM Peters, AME Walenkamp, IP Kema, C Meijer, EGE de Vries, ...
Drug Resistance Updates 17 (4-6), 96-104, 2014
922014
系统目前无法执行此操作,请稍后再试。
文章 1–20